The remarkable capabilities of the Lamborghini Temerario closely resemble the hydrodynamic finesse exhibited by ...

This financing will fund the completion of the EMPOWER Trial U.S. pivotal study and support the continued commercialization of the innovative Carillon Mitral Contour System ®. “Cardiac ...

Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s mitral valve repair device. The round was led by investment ...

To fund completion of the EMPOWER Trial U.S. pivotal study and continue the commercialization of the Carillon Mitral Contour System Cardiac Dimensions, a leader in minimally invasive treatments ...

To fund completion of the EMPOWER Trial U.S. pivotal study and continue the commercialization of the Carillon Mitral Contour System KIRKLAND, Wash., March 20, 2025--(BUSINESS WIRE)--Cardiac ...

To fund completion of the EMPOWER Trial U.S. pivotal study and continue the commercialization of the Carillon Mitral Contour System “Cardiac Dimensions is uniquely positioned to provide a safe ...

The company plans to use funds to complete a U.S. pivotal study and support the commercialization of its Carillon Mitral Contour System. Kirkland, Washington–based Cardiac Dimensions designed ...

To fund completion of the EMPOWER Trial U.S. pivotal study and continue the commercialization of the Carillon Mitral Contour System “Cardiac Dimensions is uniquely positioned to provide a safe, simple ...

US-based Cardiac Dimensions is investigating the device, called the Carillon Mitral Contour System, in the EMPOWER study (NCT03142152). The randomised trial is designed to assess the safety and ...

This financing will fund the completion of the EMPOWER Trial U.S. pivotal study and support the continued commercialization of the innovative Carillon Mitral Contour System ®. "Cardiac Dimensions is ...